Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy

Journal of Medical Virology

Volumn 55, Issue 1, 1998, Pages 7-11

  Larghi, Alberto ^a   Tagger, Alessandro ^b   Crosignani, Andrea ^a   Ribero, Maria Lisa ^b   Bruno, Savino ^a   Portera, Giuseppe ^b   Battezzati, Pier Maria ^a   Maggioni, Marco ^c   Fasola, Michele ^b   Zuin, Massimo ^a   Podda, Mauro ^a,d  

^a Ospedale San Paolo   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Ospedale San Paolo   (Italy)

^d Ospedale San Paolo   (Italy)

Author keywords

Hepatitis C virus; Interferon ; Liver HCV RNA; Long term responders; Therapy

Indexed keywords

ALPHA INTERFERON;

ANTIVIRAL ACTIVITY; ARTICLE; CHRONIC HEPATITIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; TREATMENT OUTCOME; VIRUS DETECTION;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LIVER; MALE; MIDDLE AGED; RNA, VIRAL; TIME FACTORS; TREATMENT OUTCOME;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0031830965     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199805)55:1<7::AID-JMV2>3.0.CO;2-7     Document Type: Article

References (30)

1. Bruno S, Manzin A, Roncalli M, Petroni ML, Rossi S, Pedicino M, Larghi A, Crosignani A, Podda M (1997): Histological changes but not virus eradication reflect biochemical improvement in chronic hepatitis C patients showing a long-term response to interferon α therapy. Italian Journal of Gastroenterology & Hepatology 29:31-37.
2. Chemello L, Cavalletto L, Casarin C, Bonetti P, Bernardinello E, Pontisso P, Donada C, Belussi F, Martinelli S, Alberti A, TriVeneto Viral Hepatitis Group (1996): Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-α in chronic hepatitis C. Annals of Internal Medicine 124:1058-1060.
3. Craxì A, Almasio P, Schalm S (1996a): Evaluation of efficacy of antiviral therapy for chronic hepatitis C: A EUROHEP Consensus Report on response criteria. Journal of Viral Hepatitis 3:273-276.
4. Craxì A, Di Marco V, Almasio PL (1996b): Hepatic hepatitis C virus RNA in chronic hepatitis C. Annals of Internal Medicine 124:72 (letter).
5. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ (1994): Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 19:1513-1520.
6. Donate F, Tagger A, Chiesa R, Ribero ML, Tomasoni V, Fasola M, Gelatti U, Portera G, Boffetta P, Nardi G (1997): Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: A case-control study in Italy. Hepatology 26:579-584.
7. Fried MW, Hoofnagle JH (1995): Therapy of hepatitis C. Seminar in Liver Diseases 15:82-91.
8. Guido M, Thung SN (1996): The value of identifying hepatitis C virus in liver pathology specimens. Hepatology 23:376-379.
9. Honda M, Kaneko S, Sakai A, Unoura M, Murakami S, Kobayashi K (1994): Degree of diversity of hepatitis C virus quasispecies and progression of liver disease. Hepatology 20:1144-1151.
10. Idrovo V, Dailey PJ, Jeffers LJ, Coelho-Little E, Bernstein D, Bartholomew M, Alvarez L, Urdea MS, Collins ML, Schiff ER (1996): Hepatitis C virus RNA quantification in right and left lobes of the liver in patients with chronic hepatitis C. Journal of Viral Hepatitis 3:239-246.
11. Kakumo S, Yoshika K, Tanaka K, Higashi Y, Kurokawa S, Hirofuji H, Kusakabe A (1993): Long-term carriage of hepatitis C virus with normal aminotransferase after interferon treatment in patients with chronic hepatitis C. Journal of Medical Virology 41:65-70.
12. Lau JYN, Mizokami M, Ohno T, Diamond DA, Kniffen J, Davis GL (1993): Discrepancy between biochemical and virological responses to interferon-α in chronic hepatitis C. Lancet 342:1208-1209.
13. Marcellin P, Boyer N, Degott C, Martinot-Peignoux M, Duchatelle V, Giostra E, Areias J, Erlinger S, Benhamou J-P (1994): Long-term histologic and viral changes in patients with chronic hepatitis C who responded to alpha interferon. Liver 14:302-307.
14. Martell M, Esteban JI, Quer J, Genesca J, Weiner A, Esteban R, Guardia J, Gomez J (1992): Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: Quasispecies nature of HCV genome distribution. Journal of Medical Virology 66:3225-3229.
15. 2b therapy in patients with chronic hepatitis C. Digestive Disease and Science 39:1273-1780.
16. Nakagawa H, Shimomura H, Hasui T, Tsuji H, Tsuji T (1994): Quantitative detection of hepatitis C virus genome in liver tissue and circulation by competitive reverse transcription-polymerase chain reaction. Digestive Disease and Science 39:225-233.
17. 2b for 60 weeks. Hepatology 19: 280-285.
18. Reichard O, Glaumann H, Fryden A, Norkrans G, Schvarcz R, Sonnerborg A, Yun ZB, Weiland O (1995): Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment. Hepatology 21:918-922.
19. Ribero ML, Tremolada F, Chiaramonte S, Rapicetta M, Pregliasco F, Fasola M, Ciccaglione A, Cristiano K, Tagger A (1993): HCV detection in different NANB hepatitis patients groups. In Polders I, Stuyck M (eds): New Challenges in the Blood Bank Environment. Turnout, Belgium: Interface Proceedings, pp 7-10.
20. Romeo R, Pol S, Berthelot P, Brechot C (1994): Eradication of hepatitis C virus RNA after alpha-interferon therapy. Annals of Internal Medicine 121:276-277.
21. Saracco G, Abate ML, Baldi M, Calvo PL, Manzini P, Brunetto MR, Oliveri F, Kuo G, Chien D, Houghton M, Verme G, Rizzetto M, Bonino F (1994): Hepatitis C virus markers in patients with long-term biochemical and histological remission of chronic hepatitis. Liver 14:65-70.
22. Sharara AI, Hunt CM, Hamilton JD (1996): Hepatitis C. Annals of Internal Medicine 125:658-668.
23. Shindo M, Di Bisceglie AM, Cheung L, Wai-Kuo Shih J, Cristiano K, Feinstone SM, Hoofnagle JH (1991): Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Annals of Internal Medicine 115:700-704.
24. Shindo M, Di Bisceglie AM, Hoofnagle JH (1992): Long-term follow-up of patients with chronic hepatitis C treated with α-interferon. Hepatology 15:1013-1016.
25. Shindo M, Arai K, Sokowa Y, Okuno T (1995): Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-α therapy. Annals of Internal Medicine 122:586-591.
26. Shindo M, Okuno T (1996): Hepatic hepatitis C virus RNA in chronic hepatitis C. Annals of Internal Medicine 124:72 (reply).
27. Terrault N, Wright T (1995): Interferon and hepatitis C. New England Journal of Medicine 332:1509-1511.
28. Vento S, Concia E, Ferraro T (1996): Lack of sustained efficacy of interferon in patients with chronic hepatitis C. New England Journal of Medicine 334:1479-1480.
29. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, Crawford KA, Brunetto M, Barr PJ, Miyamura T, McHutchinson J, Houghton M (1992): Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: Potential role in chronic HCV infection. Proceedings of the National Academy of Sciences USA 89:3468-3472.
30. Zaaijer HL, Cuypers HTM, Reesink HW, Winkel IN, Gerken G, Lelie PN (1993): Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 341:722-724.